Omeros News

Omeros Corporation to Announce First Quarter Financial Results on May 15, 2024

Omeros Corporation (NASDAQ: OMER), today announced that the company will issue its financial results for the quarter and year ended March 31, 2024, on Wednesday, May 15, 2024, after the market closes. Omeros management will host a conference call and webcast that same day at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) to discuss the financial results as well as recent developments and highlights.

BusinesswireMay 10 20:50 · Earnings

Omeros Corporation Announces Upcoming Presentations at 2024 European Hematology Association (EHA) Hybrid Congress

Omeros Corporation (Nasdaq: OMER) today announced that interim analysis data from its ongoing Phase 2 study of OMS906 in patients with paroxysmal nocturnal hemoglobinuria submitted to the 2024 European Hematology Association (EHA) Hybrid Congress has been selected for podium presentation.

BusinesswireMay 9 20:50

Analysts Offer Insights on Healthcare Companies: Oric Pharmaceuticals (ORIC), Omeros (OMER) and Urogen Pharma (URGN)

TipRanksApr 9 19:40

Omeros Corporation's $50M Buyback Plan: A Double-Edged Sword for Stock Stability

TipRanksApr 3 14:01

Omeros Shares Down 6% on Swing to 4Q Loss

By Denny Jacob Omeros shares edged down 6% to $3 a reporting a swing to a loss in the fourth quarter. The stock is down 8.3% so far this year. The biopharmaceutical company posted a loss of $9.1 mi

WSJApr 2 23:07

Omeros (OMER) Gets a Hold From Needham

TipRanksApr 2 18:27

Earnings Call Summary | Omeros(OMER.US) Q4 2023 Earnings Conference

The following is a summary of the Omeros Corporation (OMER) Q4 2023 Earnings Call Transcript:Financial Performance:Omeros reported a Q4 2023 net loss of $9.1 million, or $0.15 per share, compared to a

Futu NewsApr 2 09:28 · Conference Call

Omeros Corp. Q4 Earnings Summary

RTTNewsApr 2 04:40

Omeros Swings to Q4 Net Loss; Q1 Outlook Set

Omeros (OMER) reported a Q4 net loss late Monday of $0.15 per diluted share, compared with earnings of $2.05 a year earlier.

MT NewswiresApr 2 04:33

Omeros Q4 2023 GAAP EPS $(0.15) Beats $(0.56) Estimate

Omeros (NASDAQ:OMER) reported quarterly losses of $(0.15) per share which beat the analyst consensus estimate of $(0.56) by 73.21 percent.

BenzingaApr 2 04:03

Omeros 4Q Loss $9.07M >OMER

Omeros 4Q Loss $9.07M >OMER

Dow JonesApr 2 04:02

Press Release: Omeros Corporation Reports Fourth Quarter and Year-End 2023 Financial Results

Omeros Corporation Reports Fourth Quarter and Year-End 2023 Financial Results -- Conference Call Today at 4:30 p.m. ET SEATTLE--(BUSINESS WIRE)--April 01, 2024-- Omeros Corporation (Nasdaq: OMER),

Dow JonesApr 2 04:02

Earnings Scheduled For April 1, 2024

Companies Reporting Before The Bell • Mach Natural Resources (NYSE:MNR) is projected to report quarterly earnings at $0.92 per share on revenue of $213.43 million. • Sharps Technology (NASDAQ:STSS) is

BenzingaApr 1 17:13

Investor Sentiment Edges Lower, US Stocks Record Gains Last Quarter

The CNN Money Fear and Greed index showed a slight decline in overall market sentiment, but it remained in the "Greed" zone on Thursday. U.S. stocks closed mixed on Thursday, while the S&P 500 surged

BenzingaApr 1 15:35

Omeros Q4 2023 Earnings Preview

Seeking AlphaApr 1 05:35

Press Release: Omeros Corporation to Announce Fourth Quarter and Year-End Financial Results on April 1, 2024

Omeros Corporation to Announce Fourth Quarter and Year-End Financial Results on April 1, 2024 SEATTLE--(BUSINESS WIRE)--March 27, 2024-- Omeros Corporation (NASDAQ: OMER), today announced that the c

Dow JonesMar 27 20:30

12 Health Care Stocks Moving In Monday's After-Market Session

GainersStoke Therapeutics (NASDAQ:STOK) shares increased by 77.7% to $11.55 during Monday's after-market session. The company's market cap stands at $515.7 million. As per the news, the Q4 earnings re

BenzingaMar 26 05:32

Tesla, Spirit Airlines, New York Community Bancorp And Other Big Stocks Moving Lower On Monday

U.S. stocks were lower, with the Dow Jones index falling around 80 points on Monday. Shares of Tesla, Inc. (NASDAQ:TSLA) fell during Monday's session after the company reportedly saw a decline in Fe

BenzingaMar 4 23:40

Omeros Announces Upcoming Presentation Detailing Narsoplimab Compassionate Use In Nine Patients With Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy

Omeros Corporation (NASDAQ:OMER) today announced the upcoming presentation of a report detailing narsoplimab treatment in nine adult patients with hematopoietic stem cell transplant-associated thrombo

BenzingaFeb 20 22:15

Omeros Expands Royalty Deal With DRI for OMIDRIA Sales

TipRanksFeb 8 17:11